CLYM:NASDAQ, Climb Bio, Inc.

CLYM stock overview

Climb Bio, Inc. (CLYM:NASDAQ) closed at $9.28 on November 19, 2026, down 0.22% on the day. The stock trades 49.4% below its 52-week high of $18.33 and 467.6% above its 52-week low of $1.64. Over the past year, it gained 445.9%. Climb Bio, Inc. is part of the Health Care sector.

Key figures

Price
$9.28
Day change
-0.22%
Volume
586,596
Average volume
1,383,237
Market cap
545M+
52-week range
$1.64 – $18.33
50-day average
$11.23
200-day average
$10.74

Price action over the past year

In 252 trading sessions since November 19, 2025, CLYM closed higher on 131 days (52%). Its best day was December 12, 2025 (+30.43%) and its worst was October 26, 2026 (-13.54%). The stock moved 10% or more in a single session 21 times.

Recent signals

CLYM news

About Climb Bio, Inc.

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Similar stocks

Find more stocks like CLYM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.